Amdocs Limited (NASDAQ:DOX) Shares Sold by Vanguard Personalized Indexing Management LLC

Posted by Defense World Staff on Aug 30th, 2023

Vanguard Personalized Indexing Management LLC lowered its stake in shares of Amdocs Limited (NASDAQ:DOX – Free Report) by 11.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,446 shares of the technology company’s stock after selling 547 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Amdocs were worth $427,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of the stock. Machina Capital S.A.S. acquired a new stake in shares of Amdocs in the first quarter valued at about $41,000. U.S. Capital Wealth Advisors LLC purchased a new position in Amdocs in the 4th quarter worth approximately $47,000. Belpointe Asset Management LLC acquired a new position in shares of Amdocs during the 4th quarter worth approximately $79,000. Zions Bancorporation N.A. purchased a new stake in shares of Amdocs in the first quarter valued at approximately $83,000. Finally, Brown Brothers Harriman & Co. increased its holdings in shares of Amdocs by 787.2% in the first quarter. Brown Brothers Harriman & Co. now owns 1,180 shares of the technology company’s stock valued at $97,000 after purchasing an additional 1,047 shares during the last quarter. Institutional investors and hedge funds own 90.58% of the company’s stock.

Wall Street Analyst Weigh In

DOX has been the topic of a number of recent research reports. Barclays raised Amdocs from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $100.00 to $115.00 in a research note on Tuesday, May 16th. Oppenheimer lifted their target price on shares of Amdocs from $99.00 to $109.00 and gave the stock an “outperform” rating in a research note on Thursday, August 3rd. StockNews.com began coverage on shares of Amdocs in a research note on Thursday, August 17th. They issued a “buy” rating for the company. Bank of America lifted their price target on shares of Amdocs from $100.00 to $110.00 in a research report on Friday, June 16th. Finally, 888 reiterated a “reiterates” rating on shares of Amdocs in a research report on Thursday, May 11th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, Amdocs currently has a consensus rating of “Moderate Buy” and a consensus target price of $106.00.

Get Our Latest Analysis on Amdocs

Amdocs Stock Up 1.1 %

NASDAQ:DOX opened at $88.32 on Wednesday. Amdocs Limited has a 52 week low of $78.02 and a 52 week high of $99.75. The stock’s fifty day moving average is $92.92 and its two-hundred day moving average is $93.36. The stock has a market capitalization of $10.67 billion, a price-to-earnings ratio of 18.91, a price-to-earnings-growth ratio of 1.50 and a beta of 0.65. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.21.

Amdocs (NASDAQ:DOX – Get Free Report) last posted its earnings results on Wednesday, August 2nd. The technology company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.08. The firm had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.23 billion. Amdocs had a return on equity of 17.60% and a net margin of 11.80%. Research analysts anticipate that Amdocs Limited will post 5.31 EPS for the current year.

Amdocs Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be issued a dividend of $0.435 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.74 dividend on an annualized basis and a yield of 1.97%. Amdocs’s dividend payout ratio (DPR) is presently 37.26%.

About Amdocs

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES21, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; the Commerce and Care suite for order capture, handling, and customer engagement; the Monetization suite for charging, billing, policy, and revenue management; Intelligent Networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; MarketONE, a cloud-native business ecosystem; Digital Brands Suite, a pre-integrated digital business suite for digital telecom brands and small-scale service providers; and eSIM Cloud for service providers.